Shares of OpGen Inc (NASDAQ:OPGN) shot up 6.8% during mid-day trading on Wednesday . The company traded as high as $2.30 and last traded at $2.20. 537,199 shares were traded during mid-day trading, an increase of 21% from the average session volume of 445,546 shares. The stock had previously closed at $2.06.
A number of research firms have issued reports on OPGN. Zacks Investment Research cut shares of OpGen from a “buy” rating to a “hold” rating in a research note on Tuesday, March 13th. HC Wainwright set a $9.00 price objective on shares of OpGen and gave the stock a “buy” rating in a research note on Friday, March 16th. Finally, ValuEngine upgraded shares of OpGen from a “hold” rating to a “buy” rating in a research note on Tuesday.
Get OpGen alerts:The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.35 and a current ratio of 2.45. The company has a market capitalization of $11.57 million, a price-to-earnings ratio of -0.22 and a beta of 1.41.
OpGen (NASDAQ:OPGN) last issued its quarterly earnings data on Tuesday, May 8th. The medical research company reported ($0.75) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.84) by $0.09. OpGen had a negative net margin of 409.83% and a negative return on equity of 437.11%. The business had revenue of $0.85 million during the quarter, compared to analysts’ expectations of $0.74 million. equities research analysts forecast that OpGen Inc will post -2.34 EPS for the current fiscal year.
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing molecular information products and services to combat infectious diseases in the healthcare industry worldwide. The company utilizes molecular diagnostics and bioinformatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms.
No comments:
Post a Comment